Classical and novel biomarkers for cardiovascular risk prediction in the United States

Keyphrases

• United States 100%
• Novel Biomarkers 100%
• Cardiovascular Risk Prediction 100%
• Risk Prediction 66%
• Classical Risk Model 66%
• Epidemiologic 33%
• Cardiovascular Disease 33%
• Cardiovascular Prevention 33%
• Hemoglobin A1c (HbA1c) 33%
• Ankle-brachial Index 33%
• Patients with Diabetes 33%
• Novel Risk Factors 33%
• Risky Driving 33%
• Non-modifiable Risk Factors 33%
• C-reactive Protein 33%
• Patients with Hypertension 33%
• Clinical Measurement 33%
• Microalbuminuria 33%
• Carotid Intima-media Thickness (cIMT) 33%
• Coronary Artery Calcium 33%
• Consensus Panel 33%
• Risk Prediction Model 33%
• Lipoprotein-associated Phospholipase 33%
• Review Aspect 33%
• Intermediate Cardiovascular Risk 33%

Medicine and Dentistry

• Cardiovascular Risk 100%
• Biological Marker 100%
• Cardiovascular Disease 50%
• Primary Prevention 25%
• Isotopes of Calcium 25%
• Intima-Media Thickness 25%
• Patient with Diabetes 25%
• Hemoglobin A1c 25%
• Patient with Hypertension 25%
• Lipoprotein 25%
• Ankle Brachial Index 25%
• C Reactive Protein 25%
• Microalbuminuria 25%
• Phospholipase 25%
• Cohort Studies 25%
• Traditional Risk Factor 25%